Next Article in Journal
Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on
Next Article in Special Issue
Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer
Previous Article in Journal / Special Issue
Designer Oncolytic Adenovirus: Coming of Age
Article

Loss of Cyclin-Dependent Kinase Inhibitor Alters Oncolytic Adenovirus Replication and Promotes More Efficient Virus Production

1
Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
2
James Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
3
Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to the work.
Cancers 2018, 10(6), 202; https://doi.org/10.3390/cancers10060202
Received: 10 May 2018 / Revised: 6 June 2018 / Accepted: 11 June 2018 / Published: 15 June 2018
(This article belongs to the Special Issue Oncolytic Virotherapy)
We elucidate the role of p21/Waf-1, a cyclin-dependent kinase inhibitor, on the oncolytic infection and replication cycle of adenovirus by studying both mRNA and adenoviral proteins expression. We found that infection in the absence of p21 causes a significant increase in adenoviral genomes and late gene expression. Similarly, the oncolytic adenoviral infected p21−/− cells have earlier formation of replication foci and robust replication kinetics that were not observed in the wild type p21/Waf-1 intact cells. These findings suggest a culmination that the presence of intact p21 in host cells causes defects in the oncolytic viral life cycle which results in the production of immature and noninfectious particles. View Full-Text
Keywords: adenovirus replication; p21; oncolytic adenovirus adenovirus replication; p21; oncolytic adenovirus
Show Figures

Figure 1

MDPI and ACS Style

Höti, N.; Johnson, T.J.; Chowdhury, W.H.; Rodriguez, R. Loss of Cyclin-Dependent Kinase Inhibitor Alters Oncolytic Adenovirus Replication and Promotes More Efficient Virus Production. Cancers 2018, 10, 202. https://doi.org/10.3390/cancers10060202

AMA Style

Höti N, Johnson TJ, Chowdhury WH, Rodriguez R. Loss of Cyclin-Dependent Kinase Inhibitor Alters Oncolytic Adenovirus Replication and Promotes More Efficient Virus Production. Cancers. 2018; 10(6):202. https://doi.org/10.3390/cancers10060202

Chicago/Turabian Style

Höti, Naseruddin, Tamara J. Johnson, Wasim H. Chowdhury, and Ronald Rodriguez. 2018. "Loss of Cyclin-Dependent Kinase Inhibitor Alters Oncolytic Adenovirus Replication and Promotes More Efficient Virus Production" Cancers 10, no. 6: 202. https://doi.org/10.3390/cancers10060202

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop